Pathogenesis of and immunity to avian influenza A H5 viruses.
暂无分享,去创建一个
T. Tumpey | S. Zaki | J. Katz | Xiuhua Lu | X. Lu | T. Morken | A. Frace | X. Lu | X. Lu | A. M. Frace | S. Zaki | J. Katz | Timothy Morken
[1] T. Tumpey,et al. Depletion of Lymphocytes and Diminished Cytokine Production in Mice Infected with a Highly Virulent Influenza A (H5N1) Virus Isolated from Humans , 2000, Journal of Virology.
[2] S. Schultz-Cherry,et al. Distinct Pathogenesis of Hong Kong-Origin H5N1 Viruses in Mice Compared to That of Other Highly Pathogenic H5 Avian Influenza Viruses , 2000, Journal of Virology.
[3] William Ho,et al. Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong. , 2000, The Journal of infectious diseases.
[4] C. Bridges,et al. Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. , 1999, The Journal of infectious diseases.
[5] J. Daly,et al. Vaccines against H5N1 influenza. , 1999, Vaccine.
[6] C. Bridges,et al. Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. , 1999, The Journal of infectious diseases.
[7] N. Cox,et al. A Mouse Model for the Evaluation of Pathogenesis and Immunity to Influenza A (H5N1) Viruses Isolated from Humans , 1999, Journal of Virology.
[8] H. Goto,et al. Biological Heterogeneity, Including Systemic Replication in Mice, of H5N1 Influenza A Virus Isolates from Humans in Hong Kong , 1999, Journal of Virology.
[9] N. Cox,et al. Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. , 1999, Virology.
[10] Jonathan Y. Richmond,et al. Biosafety in microbiological and biomedical laboratories , 1999 .
[11] Y. Guan,et al. Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. , 1998, Virology.
[12] R. Webster,et al. Characterization of influenza A/HongKong/156/97 (H5N1) virus in a mouse model and protective effect of zanamivir on H5N1 infection in mice. , 1998, The Journal of infectious diseases.
[13] David E. Swayne,et al. Comparisons of Highly Virulent H5N1 Influenza A Viruses Isolated from Humans and Chickens from Hong Kong , 1998, Journal of Virology.
[14] M. Peiris,et al. Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus , 1998, The Lancet.
[15] R. Webster,et al. Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus , 1998, The Lancet.
[16] N. Cox,et al. Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. , 1998, Science.
[17] R. Webster,et al. A pandemic warning? , 1997, Nature.
[18] S. Young,et al. Adjuvant activity of the heat-labile enterotoxin from enterotoxigenic Escherichia coli for oral administration of inactivated influenza virus vaccine. , 1997, The Journal of infectious diseases.
[19] R. Webster,et al. Survey of the hemagglutinin (HA) cleavage site sequence of H5 and H7 avian influenza viruses: amino acid sequence at the HA cleavage site as a marker of pathogenicity potential. , 1996, Avian diseases.
[20] R. Belshe,et al. Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults. , 1995, The Journal of infectious diseases.
[21] K Foucar,et al. Hantavirus pulmonary syndrome. Pathogenesis of an emerging infectious disease. , 1995, The American journal of pathology.
[22] V. Hinshaw,et al. Overlapping cytotoxic T-lymphocyte and B-cell antigenic sites on the influenza virus H5 hemagglutinin , 1990, Journal of virology.
[23] R. Webster,et al. Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics , 1989, Journal of virology.
[24] V. Hinshaw,et al. Induction and activity of class II-restricted, Lyt-2+ cytolytic T lymphocytes specific for the influenza H5 hemagglutinin. , 1989, Journal of immunology.
[25] V. Hinshaw,et al. Destruction of lymphocytes by a virulent avian influenza A virus. , 1989, The Journal of general virology.
[26] C. Scholtissek,et al. On the origin of the human influenza virus subtypes H2N2 and H3N2. , 1978, Virology.
[27] L. Reed,et al. A SIMPLE METHOD OF ESTIMATING FIFTY PER CENT ENDPOINTS , 1938 .